中國廣核(003816.SZ):紅沿河5號機組預計近日具備商業運營條件
格隆匯7月30日丨中國廣核(003816.SZ)公佈,公司的聯營企業遼寧紅沿河核電有限公司(“紅沿河核電”)5號機組預計將於2021年7月31日完成所有調試工作,具備商業運營條件。
紅沿河核電還將根據相關要求辦理電力業務許可證等文件。通常情況下,相關手續完成後,上述時間將被認定為機組投入商業運營的時間。
紅沿河5號機組投入商業運營後,公司管理的在運核電機組(含聯營企業)數量增至25台,在運機組裝機容量由27142兆瓦增至28261兆瓦。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.